Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment

by Jens Reimer, Tobias Vogelmann, Daniel Trümper, Norbert Scherbaum
Published 2019-12-01

Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany – a top down approach

by Kathrin Böhmer, Henrike Schecke, Irmgard Render, Norbert Scherbaum
Published 2020-03-01

Data on deviance predictability in the assessment of mismatch negativity in patients with schizophrenia

by Magdalena Horacek, Christian Kärgel, Norbert Scherbaum, Bernhard W. Müller
Published 2016-06-01

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis

by Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano
Published 2021-07-01

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances

by Simona Pichini, Annagiulia Di Trana, Marta Torrens, Norbert Scherbaum, Simona Zaami
Published 2020-11-01

Listening to Mozart Improves Current Mood in Adult ADHD – A Randomized Controlled Pilot Study

by Marco Bernd Zimmermann, Katerina Diers, Laura Strunz, Norbert Scherbaum, Christian Mette
Published 2019-05-01

Correction: Rate of opioid use disorder in adults who received prescription opioid pain therapy-A secondary data analysis.

by Johannes M Just, Norbert Scherbaum, Michael Specka, Marie-Therese Puth, Klaus Weckbecker
Published 2021-01-01

Rate of opioid use disorder in adults who received prescription opioid pain therapy-A secondary data analysis.

by Johannes M Just, Norbert Scherbaum, Michael Specka, Marie-Therese Puth, Klaus Weckbecker
Published 2020-01-01

Chemsex and Mental Health of Men Who Have Sex With Men in Germany

by Annette Bohn, Annette Bohn, Annette Bohn, Dirk Sander, Thorsten Köhler, Nico Hees, Nico Hees, Felix Oswald, Norbert Scherbaum, Norbert Scherbaum, Daniel Deimel, Daniel Deimel, Daniel Deimel, Henrike Schecke, Henrike Schecke
Published 2020-11-01

No Clear Association between Impaired Short-Term or Working Memory Storage and Time Reproduction Capacity in Adult ADHD Patients.

by Christian Mette, Marco Grabemann, Marco Zimmermann, Laura Strunz, Norbert Scherbaum, Jens Wiltfang, Bernhard Kis
Published 2015-01-01

Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study

by Lisa Strada, Christiane Sybille Schmidt, Moritz Rosenkranz, Uwe Verthein, Norbert Scherbaum, Jens Reimer, Bernd Schulte
Published 2019-01-01

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity

by Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano
Published 2021-07-01

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

by Benedikt Bernd Claus, Michael Specka, Heath McAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet, Udo Bonnet
Published 2020-12-01

Crystal Methamphetamine Use in Sexual Settings Among German Men Who Have Sex With Men

by Henrike Schecke, Toby Lea, Toby Lea, Annette Bohn, Thorsten Köhler, Dirk Sander, Norbert Scherbaum, Daniel Deimel
Published 2019-12-01

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

by Freyja Aichholzer, Hans-Wolfgang Klafki, Isabella Ogorek, Jonathan Vogelgsang, Jens Wiltfang, Norbert Scherbaum, Sascha Weggen, Oliver Wirths
Published 2021-05-01

Alterations of monetary reward and punishment processing in chronic cannabis users: an FMRI study.

by Björn Enzi, Silke Lissek, Marc-Andreas Edel, Martin Tegenthoff, Volkmar Nicolas, Norbert Scherbaum, Georg Juckel, Patrik Roser
Published 2015-01-01

Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.

by Joerg F Schlaak, Martin Trippler, Carolina Hoyo-Becerra, Yesim Erim, Bernhard Kis, Bo Wang, Norbert Scherbaum, Guido Gerken
Published 2012-01-01

The Role of Self- and Informant-Reports on Symptoms and Impairments in the Clinical Evaluation of Adult ADHD

by Nana Guo, Anselm B. M. Fuermaier, Janneke Koerts, Bernhard W. Mueller, Christian Mette, Lara Tucha, Norbert Scherbaum, Oliver Tucha
Published 2021-04-01

A multisite randomized controlled trial of Seeking Safety vs. Relapse Prevention Training for women with co-occurring posttraumatic stress disorder and substance use disorders

by Ingo Schäfer, Annett Lotzin, Philipp Hiller, Susanne Sehner, Martin Driessen, Thomas Hillemacher, Martin Schäfer, Norbert Scherbaum, Barbara Schneider, Johanna Grundmann
Published 2019-12-01

Can reinforcement-based interventions to reduce drug use successfully be adapted to routine opioid maintenance treatment?

by Michael Specka, Antje Böning, Jürgen Kluwig, Fabrizio Schifano, Markus Banger, Wolfgang Lange, Hildegard Lax, Bärbel Marrziniak, Claudia Schüngel, Norbert Scherbaum
Published 2013-12-01